In lung transplantation, antibody-mediated rejection (AMR) diagnosed using the International Society for Heart and Lung Transplantation criteria is uncommon compared with other organs, and previous studies failed to find molecular AMR (ABMR) in lung biopsies. However, understanding of ABMR has changed with the recognition that ABMR in kidney transplants is often donor-specific antibody (DSA)-negative and associated with natural killer (NK) cell transcripts. We therefore searched for a similar molecular ABMR-like state in transbronchial biopsies using gene expression microarray results from the INTERLUNG study (#NCT02812290). After optimizing rejection-selective transcript sets in a training set (N = 488), the resulting algorithms separated an NK cell-enriched molecular rejection-like state (NKRL) from T cell-mediated rejection (TCMR)/Mixed in a test set (N = 488). Applying this approach to all 896 transbronchial biopsies distinguished 3 groups: no rejection, TCMR/Mixed, and NKRL. Like TCMR/Mixed, NKRL had increased expression of all-rejection transcripts, but NKRL had increased expression of NK cell transcripts, whereas TCMR/Mixed had increased effector T cell and activated macrophage transcripts. NKRL was usually DSA-negative and not recognized as AMR clinically. TCMR/Mixed was associated with chronic lung allograft dysfunction, reduced one-second forced expiratory volume at the time of biopsy, and short-term graft failure, but NKRL was not. Thus, some lung transplants manifest a molecular state similar to DSA-negative ABMR in kidney and heart transplants, but its clinical significance must be established.

Alfred Hospital Lung Transplant Service Melbourne Victoria Australia

Medical University of Vienna Vienna Austria

Pomeranian Medical University of Szczecin Szczecin Poland

Stanford University Stanford California USA

Toronto Lung Transplant Program University Health Network Toronto Ontario Canada

University Hospital Motol Prague Czech Republic

University of Alberta Edmonton Alberta Canada

UT Southwestern Medical Center Dallas Texas USA

Washington University in St Louis St Louis Missouri USA

Am J Transplant. 2023 Dec;23(12):1826-1827. doi: 10.1016/j.ajt.2023.08.003. PubMed

References provided by Crossref.org

Treatment Responses in Histologic Versus Molecular Diagnoses of Lung Rejection

See more in PubMed

ClinicalTrials.gov
NCT02812290